Novo Nordisk has asked the FDA to dam manufacture of compounded copies of copyright, arguing that it’s also difficult to do safely. It’s the latest escalation in a very brewing war among pharmaceutical businesses and compounders. Health officials in Big apple suspect Vitamin E oil mig